Results for first line line therapy translation from English to Slovenian

first line:
prva vrstica:

& first line:
leto (Å¡tirimestno)

first-line drug
zdravilo prve izbire

> 1st-line therapy
več kot prva linija zdravljenja

first line indent
zamik prve vrstice

advanced ovarian cancer (first-line therapy)
napredovali rak jajčnikov (zdravljenje prvega izbora)

first line doublet therapy containing alimta was not included.
dvojne terapije prvega izbora z alimto niso vključili.

change first line indent
Å tevilo tabel

first-line doublet therapy containing pemetrexed was not included.
dvojne terapije prvega izbora s pemetreksedomniso vključili.

the first line shall read:
prva vrstica se glasi:

nsclc, first-line treatment
nsclc, zdravljenje prvega izbora

first line: 36 characters (mandatory)
prva vrstica: 36 znakov (obvezno)

- oropharyngeal candidiasis: as first-line therapy in patients who have severe disease or are
- orofaringealna kandidoza: kot terapija prve izbire pri bolnikih s hudo okužbo ali pri tistih z

combination therapy in first-line treatment of metastatic colorectal cancer
kombinirano zdravljenje v prvi liniji metastatskega kolorektalnega raka

patients were required to have ecog ps 0 or 1 and to have disease progression within 6 months of the last dose of first-line therapy.
bolniki so morali imeti indeks stanja zmogljivosti ecog 0 ali 1, njihova bolezen pa je morala v zadnjih šestih mesecih od zadnjega odmerka zdravljenja prve izbire napredovati.

in the absence of risk of co-infestation, the use of a narrow spectrum parasiticide should be considered as a first line therapy.
v primeru, da ni nevarnosti za koinfestacijo, je potrebno uporabiti paraziticid z ožjim spektrom delovanja kot zdravilo prvega izbora.

advanced breast cancer and ovarian cancer (second-line therapy)
napredovali rak dojke in jajčnika (zdravljenje drugega izbora)

data from 204 patients receiving zevalin as consolidation therapy after first line remission induction:
podatki, zbrani od 204 bolnikov, ki so prejemali zdravilo zevalin kot konsolidacijsko zdravljenje po nastopu remisije z zdravljenjem prvega izbora:

in a population of patients with refractory sclc (those not responding to first line therapy), the response rate to topotecan was 4.0 %.
v skupini bolnikov z neodzivnim drobnoceličnim pljučnim rakom (obliko, ki se ne odziva na zdravljenje s terapijo prve izbire) je bil odziv na topotekan 4,0-odstoten.

maintenance nsclc therapy after first-line chemotherapy (tarceva administered as monotherapy):
vzdrževalno zdravljenje nedrobnoceličnega raka pljuč po kemoterapiji v prvi liniji (zdravilo tarceva kot samostojno zdravljenje):